Researchers identify a new chemical messenger that is critical for protecting the brain against PD.
A new study reports PINK1 triggers mitophagy, a process which breaks down and removes damaged mitochondria from cells.
According to a new study, an FDA approved drug prevented the development of Parkinson's disese in mice genetically engineered to develop the neurodegenerative disorder.
Parkinson's patients carrying mutations in PINK1 and Parkin genes have increased levels of circulating interleukin 6 and mitochondrial DNA. The findings strengthen a link between genetic risk factors from Parkinson's disease and inflammation.
Researchers report two genes associated with Parkinson's disease are also key regulators of the immune system.
A new study reports stress on the endoplasmic reticulum, and not mitochondrial failure, results in neurodegeneration in Parkinson's disease.